Digestive Tract Cancer-Related Adverse Events Correlated with Proton Pump Inhibitors Use: A Pharmacovigilance Study of the FDA Adverse Event Reporting System

Figure 1

Flowchart for studying the correlation between PPIs and digestive tract cancer risk.